Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

  • Aim to develop and manufacture the best technology graphite in the world
  • Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: Suggestion

08-01-17_money8
Rank: [?]
Vice President
Points: [?]
1016
Rating: [?]
Votes: 18 Score: 3.3
  • Currently 3.3/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Suggestion

posted on Apr 16, 09 05:27PM

Would it be possible for Dr Moro to give shareholders a specific date and time in which he would respond to shareholders' questions? It would be less stressful for Dr Moro and shareholders if he would announce a schedule upon which he felt would be reasonable to allow him time to prepare answers, but would not interfere with his obligations as CEO/CFO/Lead Scientist of Biocurex.

IMO, not knowing when, not if, is the cause for dismay amongst shareholders. IMO, specifying a date and time is much more professional and adds credibility to your committment to shareholders.

Recently, I have personally noticed a change in the pace at which medical breakthroughs have been in the media and being accepted. I am under the opinion that the medical community is finally more receptive to a "different" approach towards medical care. Examples are Myriad's genetic testing for individuals predisposed to cancer, Dendreon's vaccine for prostate cancer, reversal of the ban on embryonic stem cells. Let's add recaf to the list!!!!!



New Message

Please login to post a reply

AGORACOM Quick Tips

Breaking Small-Cap News Delivered to your Smart Phone! Grab our RSS Feed

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote